Global Custom Antibody Market Overview
The Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period.
Antibodies are host proteins produced by the body in response to the entry of foreign substances or molecules into the body. These foreign substances or molecules are called antigens and are registered by the body's immune system.
Custom antibodies offer high specificity and selectivity, and these antibodies are easier to produce than other antibodies, making them the preferred choice for all types of research studies. Factors such as increasing research activity in the life sciences industry and increasing connections between industrial and academic centers are driving the growth of the custom antibody market.
Scope of the Custom Antibody Market
The main goal of this report is to help users understand the Custom Antibody market in terms of its definition, segmentation, market potential, influential trends, and challenges facing the market. In-depth research and analysis took place while preparing the report. Readers will find this report very helpful to in-depth understanding of the market.
Covid-19 Impact on the Global Custom Antibody Market
The adoption of custom antibody services has increased for the development of COVID-19 vaccines. Vaccine-related research activities of pharmaceutical and biotech companies, research centers and academic research institutions are considered essential and have little impact on operations and production. Increasing research activity is expected to increase both the availability of research funding and the demand for antibodies, including custom antibodies.
Market Segmentation
Players Covered in Custom Antibody market are :
- Thermo Fisher Scientific
- Inc. (US)
- Bio-Rad Laboratories
- Inc. (US)
- Merck Group (Germany)
- Cell Signaling Technology
- Inc. (US)
- GenScript (China)
- BioLegend (US)
- Rockland Immunochemicals (US)
| Custom Antibody Market - Global Size & Upcoming Industry Trends | |||
|---|---|---|---|
| Segmentations | by Type |
| |
| by Source |
| ||
| by Service |
| ||
| by Research |
| ||
| by Application |
| ||
| by Region |
| ||
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Source
3.3 By Service
3.4 By Research
3.5 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 4: Custom Antibody Market by Type
4.1 Custom Antibody Market Overview Snapshot and Growth Engine
4.2 Custom Antibody Market Overview
4.3 Monoclonal Antibodies
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size (2016-2028F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Monoclonal Antibodies: Grographic Segmentation
4.4 Polyclonal Antibodies
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size (2016-2028F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Polyclonal Antibodies: Grographic Segmentation
4.5 Recombinant Antibodies
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size (2016-2028F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Recombinant Antibodies: Grographic Segmentation
4.6 Other Custom Antibodies
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size (2016-2028F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Other Custom Antibodies: Grographic Segmentation
Chapter 5: Custom Antibody Market by Source
5.1 Custom Antibody Market Overview Snapshot and Growth Engine
5.2 Custom Antibody Market Overview
5.3 Mice
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Mice: Grographic Segmentation
5.4 Rabbits
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Rabbits: Grographic Segmentation
5.5 Other Sources
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Other Sources: Grographic Segmentation
Chapter 6: Custom Antibody Market by Service
6.1 Custom Antibody Market Overview Snapshot and Growth Engine
6.2 Custom Antibody Market Overview
6.3 Antibody Development
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Antibody Development: Grographic Segmentation
6.4 Antibody Production & Purification
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Antibody Production & Purification: Grographic Segmentation
6.5 Antibody Fragmentation & Labeling
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Antibody Fragmentation & Labeling: Grographic Segmentation
Chapter 7: Custom Antibody Market by Research
7.1 Custom Antibody Market Overview Snapshot and Growth Engine
7.2 Custom Antibody Market Overview
7.3 Oncology
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size (2016-2028F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Oncology: Grographic Segmentation
7.4 Infectious Diseases
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size (2016-2028F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Infectious Diseases: Grographic Segmentation
7.5 Neurobiology
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size (2016-2028F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Neurobiology: Grographic Segmentation
7.6 Stem Cells
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size (2016-2028F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Stem Cells: Grographic Segmentation
7.7 Immunology
7.7.1 Introduction and Market Overview
7.7.2 Historic and Forecasted Market Size (2016-2028F)
7.7.3 Key Market Trends, Growth Factors and Opportunities
7.7.4 Immunology: Grographic Segmentation
7.8 Cardiovascular Disease
7.8.1 Introduction and Market Overview
7.8.2 Historic and Forecasted Market Size (2016-2028F)
7.8.3 Key Market Trends, Growth Factors and Opportunities
7.8.4 Cardiovascular Disease: Grographic Segmentation
Chapter 8: Custom Antibody Market by Application
8.1 Custom Antibody Market Overview Snapshot and Growth Engine
8.2 Custom Antibody Market Overview
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size (2016-2028F)
8.3.3 Key Market Trends, Growth Factors and Opportunities
8.3.4 Pharmaceutical & Biotechnology Companies: Grographic Segmentation
8.4 Academic & Research Institutes
8.4.1 Introduction and Market Overview
8.4.2 Historic and Forecasted Market Size (2016-2028F)
8.4.3 Key Market Trends, Growth Factors and Opportunities
8.4.4 Academic & Research Institutes: Grographic Segmentation
8.5 Contract Research Organizations
8.5.1 Introduction and Market Overview
8.5.2 Historic and Forecasted Market Size (2016-2028F)
8.5.3 Key Market Trends, Growth Factors and Opportunities
8.5.4 Contract Research Organizations: Grographic Segmentation
Chapter 9: Company Profiles and Competitive Analysis
9.1 Competitive Landscape
9.1.1 Competitive Positioning
9.1.2 Custom Antibody Sales and Market Share By Players
9.1.3 Industry BCG Matrix
9.1.4 Ansoff Matrix
9.1.5 Custom Antibody Industry Concentration Ratio (CR5 and HHI)
9.1.6 Top 5 Custom Antibody Players Market Share
9.1.7 Mergers and Acquisitions
9.1.8 Business Strategies By Top Players
9.2 THERMO FISHER SCIENTIFIC
9.2.1 Company Overview
9.2.2 Key Executives
9.2.3 Company Snapshot
9.2.4 Operating Business Segments
9.2.5 Product Portfolio
9.2.6 Business Performance
9.2.7 Key Strategic Moves and Recent Developments
9.2.8 SWOT Analysis
9.3 INC. (US)
9.4 BIO-RAD LABORATORIES
9.5 INC. (US)
9.6 MERCK GROUP (GERMANY)
9.7 CELL SIGNALING TECHNOLOGY
9.8 INC. (US)
9.9 GENSCRIPT (CHINA)
9.10 BIOLEGEND (US)
9.11 ROCKLAND IMMUNOCHEMICALS (US)
Chapter 10: Global Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
10.1 Market Overview
10.2 Historic and Forecasted Market Size By Type
10.2.1 Monoclonal Antibodies
10.2.2 Polyclonal Antibodies
10.2.3 Recombinant Antibodies
10.2.4 Other Custom Antibodies
10.3 Historic and Forecasted Market Size By Source
10.3.1 Mice
10.3.2 Rabbits
10.3.3 Other Sources
10.4 Historic and Forecasted Market Size By Service
10.4.1 Antibody Development
10.4.2 Antibody Production & Purification
10.4.3 Antibody Fragmentation & Labeling
10.5 Historic and Forecasted Market Size By Research
10.5.1 Oncology
10.5.2 Infectious Diseases
10.5.3 Neurobiology
10.5.4 Stem Cells
10.5.5 Immunology
10.5.6 Cardiovascular Disease
10.6 Historic and Forecasted Market Size By Application
10.6.1 Pharmaceutical & Biotechnology Companies
10.6.2 Academic & Research Institutes
10.6.3 Contract Research Organizations
Chapter 11: North America Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Monoclonal Antibodies
11.4.2 Polyclonal Antibodies
11.4.3 Recombinant Antibodies
11.4.4 Other Custom Antibodies
11.5 Historic and Forecasted Market Size By Source
11.5.1 Mice
11.5.2 Rabbits
11.5.3 Other Sources
11.6 Historic and Forecasted Market Size By Service
11.6.1 Antibody Development
11.6.2 Antibody Production & Purification
11.6.3 Antibody Fragmentation & Labeling
11.7 Historic and Forecasted Market Size By Research
11.7.1 Oncology
11.7.2 Infectious Diseases
11.7.3 Neurobiology
11.7.4 Stem Cells
11.7.5 Immunology
11.7.6 Cardiovascular Disease
11.8 Historic and Forecasted Market Size By Application
11.8.1 Pharmaceutical & Biotechnology Companies
11.8.2 Academic & Research Institutes
11.8.3 Contract Research Organizations
11.9 Historic and Forecast Market Size by Country
11.9.1 U.S.
11.9.2 Canada
11.9.3 Mexico
Chapter 12: Europe Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Monoclonal Antibodies
12.4.2 Polyclonal Antibodies
12.4.3 Recombinant Antibodies
12.4.4 Other Custom Antibodies
12.5 Historic and Forecasted Market Size By Source
12.5.1 Mice
12.5.2 Rabbits
12.5.3 Other Sources
12.6 Historic and Forecasted Market Size By Service
12.6.1 Antibody Development
12.6.2 Antibody Production & Purification
12.6.3 Antibody Fragmentation & Labeling
12.7 Historic and Forecasted Market Size By Research
12.7.1 Oncology
12.7.2 Infectious Diseases
12.7.3 Neurobiology
12.7.4 Stem Cells
12.7.5 Immunology
12.7.6 Cardiovascular Disease
12.8 Historic and Forecasted Market Size By Application
12.8.1 Pharmaceutical & Biotechnology Companies
12.8.2 Academic & Research Institutes
12.8.3 Contract Research Organizations
12.9 Historic and Forecast Market Size by Country
12.9.1 Germany
12.9.2 U.K.
12.9.3 France
12.9.4 Italy
12.9.5 Russia
12.9.6 Spain
Chapter 13: Asia-Pacific Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Monoclonal Antibodies
13.4.2 Polyclonal Antibodies
13.4.3 Recombinant Antibodies
13.4.4 Other Custom Antibodies
13.5 Historic and Forecasted Market Size By Source
13.5.1 Mice
13.5.2 Rabbits
13.5.3 Other Sources
13.6 Historic and Forecasted Market Size By Service
13.6.1 Antibody Development
13.6.2 Antibody Production & Purification
13.6.3 Antibody Fragmentation & Labeling
13.7 Historic and Forecasted Market Size By Research
13.7.1 Oncology
13.7.2 Infectious Diseases
13.7.3 Neurobiology
13.7.4 Stem Cells
13.7.5 Immunology
13.7.6 Cardiovascular Disease
13.8 Historic and Forecasted Market Size By Application
13.8.1 Pharmaceutical & Biotechnology Companies
13.8.2 Academic & Research Institutes
13.8.3 Contract Research Organizations
13.9 Historic and Forecast Market Size by Country
13.9.1 China
13.9.2 India
13.9.3 Japan
13.9.4 Southeast Asia
Chapter 14: South America Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Monoclonal Antibodies
14.4.2 Polyclonal Antibodies
14.4.3 Recombinant Antibodies
14.4.4 Other Custom Antibodies
14.5 Historic and Forecasted Market Size By Source
14.5.1 Mice
14.5.2 Rabbits
14.5.3 Other Sources
14.6 Historic and Forecasted Market Size By Service
14.6.1 Antibody Development
14.6.2 Antibody Production & Purification
14.6.3 Antibody Fragmentation & Labeling
14.7 Historic and Forecasted Market Size By Research
14.7.1 Oncology
14.7.2 Infectious Diseases
14.7.3 Neurobiology
14.7.4 Stem Cells
14.7.5 Immunology
14.7.6 Cardiovascular Disease
14.8 Historic and Forecasted Market Size By Application
14.8.1 Pharmaceutical & Biotechnology Companies
14.8.2 Academic & Research Institutes
14.8.3 Contract Research Organizations
14.9 Historic and Forecast Market Size by Country
14.9.1 Brazil
14.9.2 Argentina
Chapter 15: Middle East & Africa Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
15.1 Key Market Trends, Growth Factors and Opportunities
15.2 Impact of Covid-19
15.3 Key Players
15.4 Key Market Trends, Growth Factors and Opportunities
15.4 Historic and Forecasted Market Size By Type
15.4.1 Monoclonal Antibodies
15.4.2 Polyclonal Antibodies
15.4.3 Recombinant Antibodies
15.4.4 Other Custom Antibodies
15.5 Historic and Forecasted Market Size By Source
15.5.1 Mice
15.5.2 Rabbits
15.5.3 Other Sources
15.6 Historic and Forecasted Market Size By Service
15.6.1 Antibody Development
15.6.2 Antibody Production & Purification
15.6.3 Antibody Fragmentation & Labeling
15.7 Historic and Forecasted Market Size By Research
15.7.1 Oncology
15.7.2 Infectious Diseases
15.7.3 Neurobiology
15.7.4 Stem Cells
15.7.5 Immunology
15.7.6 Cardiovascular Disease
15.8 Historic and Forecasted Market Size By Application
15.8.1 Pharmaceutical & Biotechnology Companies
15.8.2 Academic & Research Institutes
15.8.3 Contract Research Organizations
15.9 Historic and Forecast Market Size by Country
15.9.1 Saudi Arabia
15.9.2 South Africa
Chapter 16 Investment Analysis
Chapter 17 Analyst Viewpoint and Conclusion
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Source
3.3 By Service
3.4 By Research
3.5 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 4: Custom Antibody Market by Type
4.1 Custom Antibody Market Overview Snapshot and Growth Engine
4.2 Custom Antibody Market Overview
4.3 Monoclonal Antibodies
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size (2016-2028F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Monoclonal Antibodies: Grographic Segmentation
4.4 Polyclonal Antibodies
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size (2016-2028F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Polyclonal Antibodies: Grographic Segmentation
4.5 Recombinant Antibodies
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size (2016-2028F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Recombinant Antibodies: Grographic Segmentation
4.6 Other Custom Antibodies
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size (2016-2028F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Other Custom Antibodies: Grographic Segmentation
Chapter 5: Custom Antibody Market by Source
5.1 Custom Antibody Market Overview Snapshot and Growth Engine
5.2 Custom Antibody Market Overview
5.3 Mice
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Mice: Grographic Segmentation
5.4 Rabbits
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Rabbits: Grographic Segmentation
5.5 Other Sources
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Other Sources: Grographic Segmentation
Chapter 6: Custom Antibody Market by Service
6.1 Custom Antibody Market Overview Snapshot and Growth Engine
6.2 Custom Antibody Market Overview
6.3 Antibody Development
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Antibody Development: Grographic Segmentation
6.4 Antibody Production & Purification
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Antibody Production & Purification: Grographic Segmentation
6.5 Antibody Fragmentation & Labeling
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Antibody Fragmentation & Labeling: Grographic Segmentation
Chapter 7: Custom Antibody Market by Research
7.1 Custom Antibody Market Overview Snapshot and Growth Engine
7.2 Custom Antibody Market Overview
7.3 Oncology
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size (2016-2028F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Oncology: Grographic Segmentation
7.4 Infectious Diseases
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size (2016-2028F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Infectious Diseases: Grographic Segmentation
7.5 Neurobiology
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size (2016-2028F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Neurobiology: Grographic Segmentation
7.6 Stem Cells
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size (2016-2028F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Stem Cells: Grographic Segmentation
7.7 Immunology
7.7.1 Introduction and Market Overview
7.7.2 Historic and Forecasted Market Size (2016-2028F)
7.7.3 Key Market Trends, Growth Factors and Opportunities
7.7.4 Immunology: Grographic Segmentation
7.8 Cardiovascular Disease
7.8.1 Introduction and Market Overview
7.8.2 Historic and Forecasted Market Size (2016-2028F)
7.8.3 Key Market Trends, Growth Factors and Opportunities
7.8.4 Cardiovascular Disease: Grographic Segmentation
Chapter 8: Custom Antibody Market by Application
8.1 Custom Antibody Market Overview Snapshot and Growth Engine
8.2 Custom Antibody Market Overview
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size (2016-2028F)
8.3.3 Key Market Trends, Growth Factors and Opportunities
8.3.4 Pharmaceutical & Biotechnology Companies: Grographic Segmentation
8.4 Academic & Research Institutes
8.4.1 Introduction and Market Overview
8.4.2 Historic and Forecasted Market Size (2016-2028F)
8.4.3 Key Market Trends, Growth Factors and Opportunities
8.4.4 Academic & Research Institutes: Grographic Segmentation
8.5 Contract Research Organizations
8.5.1 Introduction and Market Overview
8.5.2 Historic and Forecasted Market Size (2016-2028F)
8.5.3 Key Market Trends, Growth Factors and Opportunities
8.5.4 Contract Research Organizations: Grographic Segmentation
Chapter 9: Company Profiles and Competitive Analysis
9.1 Competitive Landscape
9.1.1 Competitive Positioning
9.1.2 Custom Antibody Sales and Market Share By Players
9.1.3 Industry BCG Matrix
9.1.4 Ansoff Matrix
9.1.5 Custom Antibody Industry Concentration Ratio (CR5 and HHI)
9.1.6 Top 5 Custom Antibody Players Market Share
9.1.7 Mergers and Acquisitions
9.1.8 Business Strategies By Top Players
9.2 THERMO FISHER SCIENTIFIC
9.2.1 Company Overview
9.2.2 Key Executives
9.2.3 Company Snapshot
9.2.4 Operating Business Segments
9.2.5 Product Portfolio
9.2.6 Business Performance
9.2.7 Key Strategic Moves and Recent Developments
9.2.8 SWOT Analysis
9.3 INC. (US)
9.4 BIO-RAD LABORATORIES
9.5 INC. (US)
9.6 MERCK GROUP (GERMANY)
9.7 CELL SIGNALING TECHNOLOGY
9.8 INC. (US)
9.9 GENSCRIPT (CHINA)
9.10 BIOLEGEND (US)
9.11 ROCKLAND IMMUNOCHEMICALS (US)
Chapter 10: Global Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
10.1 Market Overview
10.2 Historic and Forecasted Market Size By Type
10.2.1 Monoclonal Antibodies
10.2.2 Polyclonal Antibodies
10.2.3 Recombinant Antibodies
10.2.4 Other Custom Antibodies
10.3 Historic and Forecasted Market Size By Source
10.3.1 Mice
10.3.2 Rabbits
10.3.3 Other Sources
10.4 Historic and Forecasted Market Size By Service
10.4.1 Antibody Development
10.4.2 Antibody Production & Purification
10.4.3 Antibody Fragmentation & Labeling
10.5 Historic and Forecasted Market Size By Research
10.5.1 Oncology
10.5.2 Infectious Diseases
10.5.3 Neurobiology
10.5.4 Stem Cells
10.5.5 Immunology
10.5.6 Cardiovascular Disease
10.6 Historic and Forecasted Market Size By Application
10.6.1 Pharmaceutical & Biotechnology Companies
10.6.2 Academic & Research Institutes
10.6.3 Contract Research Organizations
Chapter 11: North America Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Monoclonal Antibodies
11.4.2 Polyclonal Antibodies
11.4.3 Recombinant Antibodies
11.4.4 Other Custom Antibodies
11.5 Historic and Forecasted Market Size By Source
11.5.1 Mice
11.5.2 Rabbits
11.5.3 Other Sources
11.6 Historic and Forecasted Market Size By Service
11.6.1 Antibody Development
11.6.2 Antibody Production & Purification
11.6.3 Antibody Fragmentation & Labeling
11.7 Historic and Forecasted Market Size By Research
11.7.1 Oncology
11.7.2 Infectious Diseases
11.7.3 Neurobiology
11.7.4 Stem Cells
11.7.5 Immunology
11.7.6 Cardiovascular Disease
11.8 Historic and Forecasted Market Size By Application
11.8.1 Pharmaceutical & Biotechnology Companies
11.8.2 Academic & Research Institutes
11.8.3 Contract Research Organizations
11.9 Historic and Forecast Market Size by Country
11.9.1 U.S.
11.9.2 Canada
11.9.3 Mexico
Chapter 12: Europe Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Monoclonal Antibodies
12.4.2 Polyclonal Antibodies
12.4.3 Recombinant Antibodies
12.4.4 Other Custom Antibodies
12.5 Historic and Forecasted Market Size By Source
12.5.1 Mice
12.5.2 Rabbits
12.5.3 Other Sources
12.6 Historic and Forecasted Market Size By Service
12.6.1 Antibody Development
12.6.2 Antibody Production & Purification
12.6.3 Antibody Fragmentation & Labeling
12.7 Historic and Forecasted Market Size By Research
12.7.1 Oncology
12.7.2 Infectious Diseases
12.7.3 Neurobiology
12.7.4 Stem Cells
12.7.5 Immunology
12.7.6 Cardiovascular Disease
12.8 Historic and Forecasted Market Size By Application
12.8.1 Pharmaceutical & Biotechnology Companies
12.8.2 Academic & Research Institutes
12.8.3 Contract Research Organizations
12.9 Historic and Forecast Market Size by Country
12.9.1 Germany
12.9.2 U.K.
12.9.3 France
12.9.4 Italy
12.9.5 Russia
12.9.6 Spain
Chapter 13: Asia-Pacific Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Monoclonal Antibodies
13.4.2 Polyclonal Antibodies
13.4.3 Recombinant Antibodies
13.4.4 Other Custom Antibodies
13.5 Historic and Forecasted Market Size By Source
13.5.1 Mice
13.5.2 Rabbits
13.5.3 Other Sources
13.6 Historic and Forecasted Market Size By Service
13.6.1 Antibody Development
13.6.2 Antibody Production & Purification
13.6.3 Antibody Fragmentation & Labeling
13.7 Historic and Forecasted Market Size By Research
13.7.1 Oncology
13.7.2 Infectious Diseases
13.7.3 Neurobiology
13.7.4 Stem Cells
13.7.5 Immunology
13.7.6 Cardiovascular Disease
13.8 Historic and Forecasted Market Size By Application
13.8.1 Pharmaceutical & Biotechnology Companies
13.8.2 Academic & Research Institutes
13.8.3 Contract Research Organizations
13.9 Historic and Forecast Market Size by Country
13.9.1 China
13.9.2 India
13.9.3 Japan
13.9.4 Southeast Asia
Chapter 14: South America Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Monoclonal Antibodies
14.4.2 Polyclonal Antibodies
14.4.3 Recombinant Antibodies
14.4.4 Other Custom Antibodies
14.5 Historic and Forecasted Market Size By Source
14.5.1 Mice
14.5.2 Rabbits
14.5.3 Other Sources
14.6 Historic and Forecasted Market Size By Service
14.6.1 Antibody Development
14.6.2 Antibody Production & Purification
14.6.3 Antibody Fragmentation & Labeling
14.7 Historic and Forecasted Market Size By Research
14.7.1 Oncology
14.7.2 Infectious Diseases
14.7.3 Neurobiology
14.7.4 Stem Cells
14.7.5 Immunology
14.7.6 Cardiovascular Disease
14.8 Historic and Forecasted Market Size By Application
14.8.1 Pharmaceutical & Biotechnology Companies
14.8.2 Academic & Research Institutes
14.8.3 Contract Research Organizations
14.9 Historic and Forecast Market Size by Country
14.9.1 Brazil
14.9.2 Argentina
Chapter 15: Middle East & Africa Custom Antibody Market Analysis, Insights and Forecast, 2016-2028
15.1 Key Market Trends, Growth Factors and Opportunities
15.2 Impact of Covid-19
15.3 Key Players
15.4 Key Market Trends, Growth Factors and Opportunities
15.4 Historic and Forecasted Market Size By Type
15.4.1 Monoclonal Antibodies
15.4.2 Polyclonal Antibodies
15.4.3 Recombinant Antibodies
15.4.4 Other Custom Antibodies
15.5 Historic and Forecasted Market Size By Source
15.5.1 Mice
15.5.2 Rabbits
15.5.3 Other Sources
15.6 Historic and Forecasted Market Size By Service
15.6.1 Antibody Development
15.6.2 Antibody Production & Purification
15.6.3 Antibody Fragmentation & Labeling
15.7 Historic and Forecasted Market Size By Research
15.7.1 Oncology
15.7.2 Infectious Diseases
15.7.3 Neurobiology
15.7.4 Stem Cells
15.7.5 Immunology
15.7.6 Cardiovascular Disease
15.8 Historic and Forecasted Market Size By Application
15.8.1 Pharmaceutical & Biotechnology Companies
15.8.2 Academic & Research Institutes
15.8.3 Contract Research Organizations
15.9 Historic and Forecast Market Size by Country
15.9.1 Saudi Arabia
15.9.2 South Africa
Chapter 16 Investment Analysis
Chapter 17 Analyst Viewpoint and Conclusion
| Custom Antibody Market - Global Size & Upcoming Industry Trends | |||
|---|---|---|---|
| Segmentations | by Type |
| |
| by Source |
| ||
| by Service |
| ||
| by Research |
| ||
| by Application |
| ||
| by Region |
| ||
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CUSTOM ANTIBODY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CUSTOM ANTIBODY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CUSTOM ANTIBODY MARKET COMPETITIVE RIVALRY
TABLE 005. CUSTOM ANTIBODY MARKET THREAT OF NEW ENTRANTS
TABLE 006. CUSTOM ANTIBODY MARKET THREAT OF SUBSTITUTES
TABLE 007. CUSTOM ANTIBODY MARKET BY TYPE
TABLE 008. MONOCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 009. POLYCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 010. RECOMBINANT ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 011. OTHER CUSTOM ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 012. CUSTOM ANTIBODY MARKET BY SOURCE
TABLE 013. MICE MARKET OVERVIEW (2016-2028)
TABLE 014. RABBITS MARKET OVERVIEW (2016-2028)
TABLE 015. OTHER SOURCES MARKET OVERVIEW (2016-2028)
TABLE 016. CUSTOM ANTIBODY MARKET BY SERVICE
TABLE 017. ANTIBODY DEVELOPMENT MARKET OVERVIEW (2016-2028)
TABLE 018. ANTIBODY PRODUCTION & PURIFICATION MARKET OVERVIEW (2016-2028)
TABLE 019. ANTIBODY FRAGMENTATION & LABELING MARKET OVERVIEW (2016-2028)
TABLE 020. CUSTOM ANTIBODY MARKET BY RESEARCH
TABLE 021. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 022. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
TABLE 023. NEUROBIOLOGY MARKET OVERVIEW (2016-2028)
TABLE 024. STEM CELLS MARKET OVERVIEW (2016-2028)
TABLE 025. IMMUNOLOGY MARKET OVERVIEW (2016-2028)
TABLE 026. CARDIOVASCULAR DISEASE MARKET OVERVIEW (2016-2028)
TABLE 027. CUSTOM ANTIBODY MARKET BY APPLICATION
TABLE 028. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 029. ACADEMIC & RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 030. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
TABLE 031. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 032. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 033. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 034. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 035. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 036. N CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 037. EUROPE CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 038. EUROPE CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 039. EUROPE CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 040. EUROPE CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 041. EUROPE CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 042. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 043. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 044. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 045. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 046. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 047. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 048. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 049. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 050. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 051. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 052. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 053. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 054. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 055. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 056. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 057. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 058. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 059. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 060. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 061. THERMO FISHER SCIENTIFIC: SNAPSHOT
TABLE 062. THERMO FISHER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 063. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 064. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. INC. (US): SNAPSHOT
TABLE 065. INC. (US): BUSINESS PERFORMANCE
TABLE 066. INC. (US): PRODUCT PORTFOLIO
TABLE 067. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. BIO-RAD LABORATORIES: SNAPSHOT
TABLE 068. BIO-RAD LABORATORIES: BUSINESS PERFORMANCE
TABLE 069. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 070. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. INC. (US): SNAPSHOT
TABLE 071. INC. (US): BUSINESS PERFORMANCE
TABLE 072. INC. (US): PRODUCT PORTFOLIO
TABLE 073. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. MERCK GROUP (GERMANY): SNAPSHOT
TABLE 074. MERCK GROUP (GERMANY): BUSINESS PERFORMANCE
TABLE 075. MERCK GROUP (GERMANY): PRODUCT PORTFOLIO
TABLE 076. MERCK GROUP (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. CELL SIGNALING TECHNOLOGY: SNAPSHOT
TABLE 077. CELL SIGNALING TECHNOLOGY: BUSINESS PERFORMANCE
TABLE 078. CELL SIGNALING TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 079. CELL SIGNALING TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. INC. (US): SNAPSHOT
TABLE 080. INC. (US): BUSINESS PERFORMANCE
TABLE 081. INC. (US): PRODUCT PORTFOLIO
TABLE 082. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. GENSCRIPT (CHINA): SNAPSHOT
TABLE 083. GENSCRIPT (CHINA): BUSINESS PERFORMANCE
TABLE 084. GENSCRIPT (CHINA): PRODUCT PORTFOLIO
TABLE 085. GENSCRIPT (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. BIOLEGEND (US): SNAPSHOT
TABLE 086. BIOLEGEND (US): BUSINESS PERFORMANCE
TABLE 087. BIOLEGEND (US): PRODUCT PORTFOLIO
TABLE 088. BIOLEGEND (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. ROCKLAND IMMUNOCHEMICALS (US): SNAPSHOT
TABLE 089. ROCKLAND IMMUNOCHEMICALS (US): BUSINESS PERFORMANCE
TABLE 090. ROCKLAND IMMUNOCHEMICALS (US): PRODUCT PORTFOLIO
TABLE 091. ROCKLAND IMMUNOCHEMICALS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CUSTOM ANTIBODY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CUSTOM ANTIBODY MARKET OVERVIEW BY TYPE
FIGURE 012. MONOCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 013. POLYCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 014. RECOMBINANT ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHER CUSTOM ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 016. CUSTOM ANTIBODY MARKET OVERVIEW BY SOURCE
FIGURE 017. MICE MARKET OVERVIEW (2016-2028)
FIGURE 018. RABBITS MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHER SOURCES MARKET OVERVIEW (2016-2028)
FIGURE 020. CUSTOM ANTIBODY MARKET OVERVIEW BY SERVICE
FIGURE 021. ANTIBODY DEVELOPMENT MARKET OVERVIEW (2016-2028)
FIGURE 022. ANTIBODY PRODUCTION & PURIFICATION MARKET OVERVIEW (2016-2028)
FIGURE 023. ANTIBODY FRAGMENTATION & LABELING MARKET OVERVIEW (2016-2028)
FIGURE 024. CUSTOM ANTIBODY MARKET OVERVIEW BY RESEARCH
FIGURE 025. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 026. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 027. NEUROBIOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 028. STEM CELLS MARKET OVERVIEW (2016-2028)
FIGURE 029. IMMUNOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 030. CARDIOVASCULAR DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 031. CUSTOM ANTIBODY MARKET OVERVIEW BY APPLICATION
FIGURE 032. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 033. ACADEMIC & RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 034. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
FIGURE 035. NORTH AMERICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 036. EUROPE CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 037. ASIA PACIFIC CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 038. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 039. SOUTH AMERICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CUSTOM ANTIBODY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CUSTOM ANTIBODY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CUSTOM ANTIBODY MARKET COMPETITIVE RIVALRY
TABLE 005. CUSTOM ANTIBODY MARKET THREAT OF NEW ENTRANTS
TABLE 006. CUSTOM ANTIBODY MARKET THREAT OF SUBSTITUTES
TABLE 007. CUSTOM ANTIBODY MARKET BY TYPE
TABLE 008. MONOCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 009. POLYCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 010. RECOMBINANT ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 011. OTHER CUSTOM ANTIBODIES MARKET OVERVIEW (2016-2028)
TABLE 012. CUSTOM ANTIBODY MARKET BY SOURCE
TABLE 013. MICE MARKET OVERVIEW (2016-2028)
TABLE 014. RABBITS MARKET OVERVIEW (2016-2028)
TABLE 015. OTHER SOURCES MARKET OVERVIEW (2016-2028)
TABLE 016. CUSTOM ANTIBODY MARKET BY SERVICE
TABLE 017. ANTIBODY DEVELOPMENT MARKET OVERVIEW (2016-2028)
TABLE 018. ANTIBODY PRODUCTION & PURIFICATION MARKET OVERVIEW (2016-2028)
TABLE 019. ANTIBODY FRAGMENTATION & LABELING MARKET OVERVIEW (2016-2028)
TABLE 020. CUSTOM ANTIBODY MARKET BY RESEARCH
TABLE 021. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 022. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
TABLE 023. NEUROBIOLOGY MARKET OVERVIEW (2016-2028)
TABLE 024. STEM CELLS MARKET OVERVIEW (2016-2028)
TABLE 025. IMMUNOLOGY MARKET OVERVIEW (2016-2028)
TABLE 026. CARDIOVASCULAR DISEASE MARKET OVERVIEW (2016-2028)
TABLE 027. CUSTOM ANTIBODY MARKET BY APPLICATION
TABLE 028. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 029. ACADEMIC & RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 030. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
TABLE 031. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 032. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 033. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 034. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 035. NORTH AMERICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 036. N CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 037. EUROPE CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 038. EUROPE CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 039. EUROPE CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 040. EUROPE CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 041. EUROPE CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 042. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 043. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 044. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 045. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 046. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 047. ASIA PACIFIC CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 048. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 049. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 050. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 051. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 052. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 053. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 054. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 055. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY TYPE (2016-2028)
TABLE 056. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY SOURCE (2016-2028)
TABLE 057. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY SERVICE (2016-2028)
TABLE 058. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY RESEARCH (2016-2028)
TABLE 059. SOUTH AMERICA CUSTOM ANTIBODY MARKET, BY APPLICATION (2016-2028)
TABLE 060. CUSTOM ANTIBODY MARKET, BY COUNTRY (2016-2028)
TABLE 061. THERMO FISHER SCIENTIFIC: SNAPSHOT
TABLE 062. THERMO FISHER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 063. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 064. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. INC. (US): SNAPSHOT
TABLE 065. INC. (US): BUSINESS PERFORMANCE
TABLE 066. INC. (US): PRODUCT PORTFOLIO
TABLE 067. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. BIO-RAD LABORATORIES: SNAPSHOT
TABLE 068. BIO-RAD LABORATORIES: BUSINESS PERFORMANCE
TABLE 069. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 070. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. INC. (US): SNAPSHOT
TABLE 071. INC. (US): BUSINESS PERFORMANCE
TABLE 072. INC. (US): PRODUCT PORTFOLIO
TABLE 073. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. MERCK GROUP (GERMANY): SNAPSHOT
TABLE 074. MERCK GROUP (GERMANY): BUSINESS PERFORMANCE
TABLE 075. MERCK GROUP (GERMANY): PRODUCT PORTFOLIO
TABLE 076. MERCK GROUP (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. CELL SIGNALING TECHNOLOGY: SNAPSHOT
TABLE 077. CELL SIGNALING TECHNOLOGY: BUSINESS PERFORMANCE
TABLE 078. CELL SIGNALING TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 079. CELL SIGNALING TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. INC. (US): SNAPSHOT
TABLE 080. INC. (US): BUSINESS PERFORMANCE
TABLE 081. INC. (US): PRODUCT PORTFOLIO
TABLE 082. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. GENSCRIPT (CHINA): SNAPSHOT
TABLE 083. GENSCRIPT (CHINA): BUSINESS PERFORMANCE
TABLE 084. GENSCRIPT (CHINA): PRODUCT PORTFOLIO
TABLE 085. GENSCRIPT (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. BIOLEGEND (US): SNAPSHOT
TABLE 086. BIOLEGEND (US): BUSINESS PERFORMANCE
TABLE 087. BIOLEGEND (US): PRODUCT PORTFOLIO
TABLE 088. BIOLEGEND (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. ROCKLAND IMMUNOCHEMICALS (US): SNAPSHOT
TABLE 089. ROCKLAND IMMUNOCHEMICALS (US): BUSINESS PERFORMANCE
TABLE 090. ROCKLAND IMMUNOCHEMICALS (US): PRODUCT PORTFOLIO
TABLE 091. ROCKLAND IMMUNOCHEMICALS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CUSTOM ANTIBODY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CUSTOM ANTIBODY MARKET OVERVIEW BY TYPE
FIGURE 012. MONOCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 013. POLYCLONAL ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 014. RECOMBINANT ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHER CUSTOM ANTIBODIES MARKET OVERVIEW (2016-2028)
FIGURE 016. CUSTOM ANTIBODY MARKET OVERVIEW BY SOURCE
FIGURE 017. MICE MARKET OVERVIEW (2016-2028)
FIGURE 018. RABBITS MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHER SOURCES MARKET OVERVIEW (2016-2028)
FIGURE 020. CUSTOM ANTIBODY MARKET OVERVIEW BY SERVICE
FIGURE 021. ANTIBODY DEVELOPMENT MARKET OVERVIEW (2016-2028)
FIGURE 022. ANTIBODY PRODUCTION & PURIFICATION MARKET OVERVIEW (2016-2028)
FIGURE 023. ANTIBODY FRAGMENTATION & LABELING MARKET OVERVIEW (2016-2028)
FIGURE 024. CUSTOM ANTIBODY MARKET OVERVIEW BY RESEARCH
FIGURE 025. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 026. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 027. NEUROBIOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 028. STEM CELLS MARKET OVERVIEW (2016-2028)
FIGURE 029. IMMUNOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 030. CARDIOVASCULAR DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 031. CUSTOM ANTIBODY MARKET OVERVIEW BY APPLICATION
FIGURE 032. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 033. ACADEMIC & RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 034. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
FIGURE 035. NORTH AMERICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 036. EUROPE CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 037. ASIA PACIFIC CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 038. MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 039. SOUTH AMERICA CUSTOM ANTIBODY MARKET OVERVIEW BY COUNTRY (2016-2028)
Frequently Asked Questions :
What would be forecast period in the market research report?
The forecast period in the market research report is 2021-2027.
Who are the key players in Custom Antibody market ?
The key players mentioned are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US).
What are the segments of Custom Antibody market?
The Custom Antibody market is segmented into application type, product type and region. By Application type, the market is categorized into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations. By product type, it is classified into Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Custom Antibody market?
Custom antibodies offer high specificity and selectivity, and these antibodies are easier to produce than other antibodies, making them the preferred choice for all types of research studies.
How big is the Custom Antibody market?
The Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period.
